Harga Saham
4.22
Perubahan Harian
0.05 1.20%
Bulanan
17.22%
Tahunan
495.04%
Q2 Perkiraan
4.13




Ebit Perubahan Tanggal
Acadia Pharmaceuticals USD -4.62M 22.01M 2026-03
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Almirall EUR 30.23M 12.8M 2025-12
Alnylam Pharmaceuticals USD 137.59M 108.19M 2026-03
Amarin USD -2.26M 564K 2025-12
Ardelyx USD 5.1M 2.02M 2025-12
Astellas Pharma JPY 48.57B 85.97B 2026-03
AstraZeneca USD 7.11B 4.14B 2026-03
Charles River Laboratories USD 119.9M 44.08M 2026-03
Coherus Biosciences USD -39.08M 3.65M 2025-12
Esperion Therapeutics USD 85.23M 95.19M 2025-12
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
Incyte USD 344.17M 39.71M 2026-03
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Karyopharm Therapeutics USD -17.84M 8.44M 2025-12
Lexicon Pharmaceuticals USD -14.78M 2.59M 2025-12
MacroGenics USD -12.1M 32.26M 2025-12
Moderna USD -1.39B 531M 2026-03
Myriad Genetics USD -3M 20.3M 2025-12
Pacira USD 4.62M 1.43M 2026-03
PTC Therapeutics USD 45.89M 127.51M 2026-03
Puma Biotechnology USD -2.2M 11.41M 2024-06
Sarepta Therapeutics USD 358.43M 768.52M 2026-03
Takeda JPY 257.49B 568.56B 2025-12
Ultragenyx Pharmaceutical USD -216M 102M 2026-03
Vanda Pharmaceuticals USD -10.28M 721K 2024-12